ICU Medical Inc (ICUI)

Gross profit margin

		Dec 31, 2024	Sep 30, 2024	Jun 30, 2024	Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020
Gross profit (ttm)	US$ in thousands	822,802	753,347	732,415	717,314	726,091	743,233	745,709	720,975	697,761	650,306	591,701	547,637	491,490	483,874	470,007	452,762	461,497	455,763	460,391	457,976
Revenue (ttm)	US$ in thousands	2,381,346	2,339,530	2,303,710	2,256,565	2,259,259	2,249,284	2,293,830	2,305,524	2,279,997	2,042,508	1,780,711	1,541,384	1,316,308	1,296,234	1,278,741	1,260,443	1,271,004	1,266,076	1,254,980	1,263,883
Gross profit margin		34.55%	32.20%	31.79%	31.79%	32.14%	33.04%	32.51%	31.27%	30.60%	31.84%	33.23%	35.53%	37.34%	37.33%	36.76%	35.92%	36.31%	36.00%	36.69%	36.24%

December 31, 2024 calculation

Gross profit margin = Gross profit (ttm) ÷ Revenue (ttm)
= $822,802K ÷ $2,381,346K
= 34.55%

The gross profit margin of ICU Medical Inc has shown fluctuations over the period under analysis.

The margin started at 36.24% as of March 31, 2020, increased to 37.34% by December 31, 2021, and then declined to 30.60% by December 31, 2022, before gradually increasing again.

The overall trend indicates some volatility, with a peak at 37.34% and a trough at 30.60%. However, it is worth noting that the margin has shown some stability in more recent periods, hovering around the 31-34% range from March 31, 2024, to December 31, 2024.

It would be prudent for stakeholders to monitor the gross profit margin closely to assess the company's ability to control production costs and maintain profitability in light of changing market conditions.